‌

EVerZom

Developer of exosome-based therapies for regenerative medicine applications.

Overview Structured Data Issues Contributors

Is a

Company attributes

Industry

Pharmaceutical industry

Health technology

Location

B2X

CEO

Jeanne Volatron

Founder

Nicolas Rousseau

Jeanne Volatron

Number of Employees (Ranges)

11 – 50

Email Address

Investors

Aloe Private Equity

Paris Business Angels

European Innovation Council

Capital Grand Est

Sorbonne Venture

Founded Date

January 1, 2019

Total Funding Amount (USD)

13,000,000

Latest Funding Round Date

October 14, 2025

Latest Funding Type

COO

Nicolas Rousseau

Country

Headquarters

Other attributes

Latest Funding Round Amount (USD)

11,700,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like EVerZom

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.